Equity Capital Markets

Company · CIK 1724521

Arcus Biosciences, Inc.

CIK1724521 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
ListedRCUS (NYSE)
First annual or quarterly report2018-05-09

Offerings

7 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-293750
ShelfEffective
2026-02-252026-10-223
333-270132
ShelfEffective
2023-02-282025-10-314
333-277224
ShelfEffective
2024-02-212024-02-211
333-267822
ShelfEffective
2022-10-112022-10-111
333-238730
ShelfEffective
2020-05-272020-05-293
333-230676
ShelfEffective
2019-04-022019-04-263
333-223086
IPOFinal prospectus
2018-02-162018-03-165

Filings

21
FiledFilingRegistrationAccession
2026-10-22424B5Shelf takedown 333-2937500001193125-26-428916
2026-10-21424B5Shelf takedown 333-2937500001193125-26-427888
2026-02-25S-3ASRShelf registered 333-2937500001193125-26-071862
2025-10-31424B5Shelf takedown 333-2701320001193125-25-260836
2025-10-30424B5Shelf takedown 333-2701320001193125-25-258794
2025-02-18424B5Shelf takedown 333-2701320001193125-25-028669
2024-02-21S-3ASRShelf registered 333-2772240001193125-24-041550
2023-02-28S-3ASRShelf registered 333-2701320001193125-23-054100
2022-10-11S-3ASRShelf registered 333-2678220001193125-22-260690
2020-05-29424B5Shelf takedown 333-2387300001193125-20-155954
2020-05-28424B5Shelf takedown 333-2387300001193125-20-153449
2020-05-27S-3ASRShelf registered 333-2387300001193125-20-153138
2019-04-26424B5Shelf takedown 333-2306760001193125-19-122574
2019-04-25EFFECTDeclared effective 333-2306769999999995-19-000834
2019-04-02S-3Shelf registered 333-2306760001193125-19-094771
2018-03-16424B4Final prospectus 333-2230860001193125-18-084508
2018-03-14EFFECTDeclared effective 333-2230869999999995-18-000599
2018-03-09S-1/AAmendment 333-2230860001193125-18-077549
2018-03-05S-1/AAmendment 333-2230860001193125-18-069517
2018-02-16S-1Registration filed 333-2230860001193125-18-048700
2017-12-15DRSDraft made public 377-018330000950123-17-011380

All filings of this company · CSV